Turn-on fluorescence sensing of histidine in body fluids: unveiling its oncogenic potential as a cancer risk biomarker

Q: What type of study is this?

This is a Experimental Study study.

Geneva Indongo; Merin K. Abraham; Greeshma Rajeevan; Arathy B. Kala; Dheyaa Mohammed Dhahir; Sony George

doi:10.1039/d5an00221d

January 1, 2025The Analyst

Turn-on fluorescence sensing of histidine in body fluids: unveiling its oncogenic potential as a cancer risk biomarker

View Full Paper

Ask AI

Bookmark

Share

Key Points

Fluorescence sensing identified histidine as a potential cancer risk biomarker, providing early diagnostic capabilities.
A limit of detection of 3.61 μM was achieved, allowing for effective histidine measurement in body fluids.
The method utilizes CuNCs quenched with Cu 2+, indicating a novel approach for selective fluorescence detection.
This study underscores the importance of histidine measurement in cancer risk assessment and biomarker development.

Implication

Fluorescence detection reveals oncogenic potential of histidine in biofluids, suggesting its role as a cancer biomarker.

Abstract

Selective fluorescence detection of histidine using CuNCs quenched with Cu 2+ enables early cancer diagnosis with a 3.61 μM limit of detection in biofluids.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Indongo et al. (2025) studied this question.

synapsesocial.com/papers/68d462b631b076d99fa619dd https://doi.org/10.1039/d5an00221d

View Full Paper

Ask AI

Bookmark

Share

Turn-on fluorescence sensing of histidine in body fluids: unveiling its oncogenic potential as a cancer risk biomarker

Key Points

Implication

Abstract

Discussion

Cite This Study

Turn-on fluorescence sensing of histidine in body fluids: unveiling its oncogenic potential as a cancer risk biomarker

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading